While growth hormone therapy has been broadly accepted as a standard treatment in PWS, supplementing gonadal hormones is a matter of debate since the early 90s, mainly because of the presumed associated behavioural changes. This evidence concerns the gene GH1 and Prader-Willi syndrome.